Miltenyi Biotec Will Highlight Tools for Dissecting the Tumor Microenvironment in a Two-part Webinar Series

Share Article

LabRoots will host the webinar May 24, in which attendees will gain a better understanding on how isolation of tumor subpopulations will enhance NGS based analyses.

Olaf Hardt, PhD Manager of R&D Oncology, Miltenyi Biotec

Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells within the tumor microenvironment is key to developing future immune-based cancer therapy strategies.

However, the most significant challenge to working with solid tumors is the need to dissociate the samples before their use in downstream applications such as immunomagnetic enrichment, flow cytometry, and single-cell sequencing. Furthermore, tumor cells can cause background signals and introduce bias to the analysis of immune cells.

In this first of two webinars, which is sponsored Miltenyi Biotec, participants will learn to optimize and automate dissociation of tumor tissue resulting in high yield, viability, and improved cell surface marker detection. They will learn best practices for the analysis of tumor cells by flow cytometry and how isolation and analysis of tumor-infiltrating immune cell subpopulations (TILs).

Dr. Olaf Hardt, a manager of R&D Oncology at Miltenyi Biotec, will be the speaker for this event. Hardt obtained his doctorate from the University of Cologne, in collaboration with Miltenyi Biotec and the IBDML in Marseille, before he started as R&D Project Manager at Miltenyi Biotec in 2008. In his current position as Manager R&D Oncology, he focuses on immuno-oncology preclinical research, target discovery, as well as oncology-related product development. He also heads the transgenic unit and animal facility.

LabRoots will host the webinar May 24, 2018, beginning at 9 a.m. PDT, 5 p.m. CET. To learn more about this event, the continuing education credits offer, or to register for free, click here.

ABOUT MILTENYI BIOTEC
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. The company’s innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Miltenyi Biotec’s technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Their more than 25 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In their commitment to the scientific community, Miltenyi Biotec also offers comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 1,500 employees in 25 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.

ABOUT LABROOTS
LabRoots is the leading scientific social networking website, which provides daily scientific trending news and science-themed apparel, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website